Icade stock hits new low at €16.17, RSI in extreme oversold territory
The office real estate company Icade continues to decline during trading on Tuesday, with a price that touched an absolute floor intraday since its stock market listing. The decline remains moderate over the day, but the underlying downward momentum is part of a heavy trend that has persisted for several months.
A new record low recorded during trading, against the backdrop of a 16% quarterly decline
The price of Icade touched €16.17 during trading on Tuesday, thus beating the previous historic low of €16.23, before recovering slightly to €16.22. The stock lost 0.43% compared to Monday's close, in a session where the SBF 120 advanced 0.26%. This new absolute low extends a slide that has accelerated sharply in recent months: the stock is down 12.28% over one month and 16.22% over three months.
An RSI in extreme oversold territory and fundamentals under pressure that shed light on the trajectory
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The RSI is at 25, in extreme oversold configuration, a level that reflects the extent of selling pressure accumulated over several weeks without a lasting rebound. The price is now below the 20-day moving average at €17.08, the 50-day moving average at €18.29 and the 200-day moving average at €19.92, representing a gap of more than 18% below the latter. This configuration reflects a prolonged deterioration, which the first-half 2026 results published on July 22 shed light on in part: Icade had then confirmed guidance for current net cash-flow between €2.90 and €3.10 per share, but signaled a decline in asset value of 3.1% on a constant perimeter basis and an expected negative reversal on lease renewals.
The average cost of debt rose to 1.85%, expected to reach around 2% by end-2026. Based on expected earnings, the stock is trading at approximately 5.4 times current fiscal year earnings according to the consensus of surveyed analysts, a low valuation that reflects the uncertainties weighing on the office real estate company in an environment of still elevated rates.
Confirmation de la guidance annuelle 2026 avec un CFNC Groupe attendu entre 2,90 € et 3,10 € par action
Risks mentioned
Baisse de valeur du patrimoine de -3,1 % à périmètre constant, dont -2,8 % sur les bureaux
Réversion négative attendue sur les renouvellements de baux, potentiel de -7,1 % sur les loyers faciaux
Coût moyen de la dette en hausse à 1,85 %, attendu à environ 2 % fin 2026 ; ICR dégradé à 3,8x
Opportunities identified
Promesse de vente des actifs de santé au Portugal, environ 75 M€ en quote-part Icade
Acquisition des 49 % de la Tour Eqho avec un rendement supérieur à 8 %, relutive sur le CFNC
Réservations résidentielles en hausse de 11,9 % en volume et 6,4 % en valeur
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
